CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
Diaphragm conditioning via phrenic nerve stimulationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02354651
NCT02354651N/ACompleted
CompareCT.gov

Response to Diaphragmatic Pacing in Subjects With Pompe Disease

University of Florida·observational·Posted Feb 3, 2015·Updated Aug 1, 2023

In Brief

An observational study evaluating Diaphragm conditioning via phrenic nerve stimulation for Pompe Disease. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the effect of diaphragm pacing on respiratory function in subjects with Pompe disease by evaluating the duration and pattern of spontaneous respiratory function versus paced ventilation respiratory function in patients with Pompe disease who have received the NeuDx Diaphragm pacer (DPS).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPompe Disease
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2015
Enrollment StartMay 1, 2013
Primary CompletionJun 1, 2022
Study CompletionJan 1, 2023
TodayJul 2, 2026
Enrollment to primary: 9.1 yearsPosted 11.4 years ago

Interventions

Diaphragm conditioning via phrenic nerve stimulationother

Diaphragm pacing will be prescribed by the patient's clinical team.